Actinium Pharmaceuticals Inc (ATNM) stock is higher by 49.73% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ATNM stock a score of 76 out of a possible 100.
That rank is primarily influenced by a fundamental score of 85. In addition to the average rating from Wall Street analysts, ATNM stock has a mean target price of 38.333. This means analysts expect the stock to gain 241.34% over the next 12 months. ATNM's rank also includes a long-term technical score of 79. The short-term technical score for ATNM is 63.
What's Happening with ATNM Stock Today
Actinium Pharmaceuticals Inc (ATNM) stock is down -1.84% while the S&P 500 is higher by 2.89% as of 11:41 AM on Monday, Nov 9. ATNM is lower by -$0.21 from the previous closing price of $11.44 on volume of 180,499 shares. Over the past year the S&P 500 has risen 16.97% while ATNM is higher by 49.73%. ATNM lost -$2.59 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Actinium Pharmaceuticals Inc (ATNM) Stock.